• Panthera's second clinical trial site in the UK, in North Manchester is open for business.
• As a standalone site ideal for existing or new trials with much lower contamination risk during COVID-19

Bio-IT World | Internet of Things measurement systems are effectively catapulting animal studies out of the horse-and-buggy era and eliminating preventable holdups due to instruments being out of date or incorrectly calibrated.

Bio-IT World | The bio-IT community continues to aggressively research and innovate for SARS-CoV-2 solutions. The latest this week includes research on drug candidates, a SARS-CoV-2 gene map, free translation services for COVID-19 researchers, and much more.

• The UK urgently needs to expand Covid-19 testing capacity for front-line healthcare workers
• There are thousands of laboratories in the UK with the right equipment and expertise to run these tests - but they are currently not being used
• SBL, a medical research laboratory in Oxfordshire, is already running 250-500 tests a week for local GPs, with same-day results
• This project, launched and funded to £1M by Mike Fischer CBE, aims to build an emergency volunteer network of laboratories willing to convert to Covid-19 testing, to supplement the Government's existing facilities
• A national network could deliver tens of thousands of additional tests per day

• The registered medical device can be downloaded for free[1].
• Good inhaler technique and optimal control is especially crucial during the Covid-19 outbreakx

Bio-IT World | TRENDS FROM THE TRENCHES | Interdisciplinary research is continuously lauded as a key to making progress in the life sciences and healthcare. But such approaches come with some particular organizational demands.

Bio-IT World | The SARS-CoV-2 virus is serving as a rallying cry across the bio-IT landscape inspiring creative new solutions, partnerships, and ideas to address the outbreak, treat and prevent the disease it causes, and address the life adjustments of our new normal.

Bio-IT World | The Bio-IT community is eager to contribute to plans for treatments, diagnostics and vaccines for COVID-19, donating consulting services, compute resources, tools for clinical trials, and so much more. But the biggest donations might be the sheer volume of data being pooled for researchers to mine for answers.